Seiki Hasegawa

Summary

Affiliation: Hyogo College of Medicine
Country: Japan

Publications

  1. ncbi Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, 663 8501, Japan
    Int J Clin Oncol 17:33-9. 2012
  2. ncbi [Current status and future direction of Japan's clinical trial for malignant pleural mesothelioma]
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, Mukogawa cho, Nishinomiya, Japan
    Nihon Eiseigaku Zasshi 66:558-61. 2011
  3. ncbi Malignant mesothelioma: current status and perspective in Japan and the world
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Japan
    Gen Thorac Cardiovasc Surg 56:317-23. 2008
  4. ncbi Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report
    Teruhisa Takuwa
    Department of General Thoracic Surgery, Hyogo College of Medicine, 1 1 Mukogawacho Nishinomiyashi Hyogo 663 8501, Japan
    Lung Cancer 68:498-500. 2010
  5. ncbi A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma
    Takeharu Yamanaka
    Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa, Nishinomiya, Hyogo, Japan
    Jpn J Clin Oncol 39:186-8. 2009
  6. ncbi Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
    Yoshie Yoshikawa
    Department of Genetics, Hyogo College of Medicine, Hyogo, Japan
    Cancer Sci 103:868-74. 2012
  7. ncbi Circulating tumor cell as a diagnostic marker in primary lung cancer
    Fumihiro Tanaka
    Departments of Thoracic Surgery, Pathology, and Thoracic Oncology, and Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
    Clin Cancer Res 15:6980-6. 2009
  8. ncbi Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM)
    Kazue Yoneda
    Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan
    Ann Surg Oncol 19:4229-37. 2012
  9. ncbi Pathological and molecular biological approaches to early mesothelioma
    Tohru Tsujimura
    Department of Pathology, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Int J Clin Oncol 17:40-7. 2012
  10. ncbi Well-differentiated papillary mesothelioma with invasion to the chest wall
    Ikuko Torii
    Department of Pathology, Hyogo College of Medicine, 1 1 Mukogawa, Nishinomiya, Hyogo 663 8501, Japan
    Lung Cancer 67:244-7. 2010

Collaborators

Detail Information

Publications37

  1. ncbi Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, 663 8501, Japan
    Int J Clin Oncol 17:33-9. 2012
    ....
  2. ncbi [Current status and future direction of Japan's clinical trial for malignant pleural mesothelioma]
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, Mukogawa cho, Nishinomiya, Japan
    Nihon Eiseigaku Zasshi 66:558-61. 2011
    ..Primary endpoints are macroscopic complete resection rate by EPP and treatment-related mortality for trimodality therapy. The study was initiated in May 2008 and patient enrollment was finished in November 2010...
  3. ncbi Malignant mesothelioma: current status and perspective in Japan and the world
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Japan
    Gen Thorac Cardiovasc Surg 56:317-23. 2008
    ..A national survey of EPP was conducted recently in Japan, and a few multicenter clinical trials will start soon...
  4. ncbi Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report
    Teruhisa Takuwa
    Department of General Thoracic Surgery, Hyogo College of Medicine, 1 1 Mukogawacho Nishinomiyashi Hyogo 663 8501, Japan
    Lung Cancer 68:498-500. 2010
    ....
  5. ncbi A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma
    Takeharu Yamanaka
    Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa, Nishinomiya, Hyogo, Japan
    Jpn J Clin Oncol 39:186-8. 2009
    ..Secondary endpoints include treatment completion rate, adverse events, response rate by chemotherapy and 2-year overall and relapse-free survival...
  6. ncbi Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
    Yoshie Yoshikawa
    Department of Genetics, Hyogo College of Medicine, Hyogo, Japan
    Cancer Sci 103:868-74. 2012
    ..These results suggest that the lack of the tumor suppressor BAP1 may be more specifically involved in the pathogenesis of epithelioid MM rather than non-epithelioid MM, and would be useful for diagnosis of epithelioid-type MM...
  7. ncbi Circulating tumor cell as a diagnostic marker in primary lung cancer
    Fumihiro Tanaka
    Departments of Thoracic Surgery, Pathology, and Thoracic Oncology, and Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
    Clin Cancer Res 15:6980-6. 2009
    ..5-mL samples of peripheral blood sampled from patients with a suspicion or a diagnosis of primary lung cancer. A semiautomated system was used to capture CTCs with an antibody against epithelial cell adhesion molecule...
  8. ncbi Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM)
    Kazue Yoneda
    Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan
    Ann Surg Oncol 19:4229-37. 2012
    ..The purpose of this study was to investigate the diagnostic and prognostic value of circulating endothelial cell (CEC), a potential surrogate of tumor angiogenesis, in malignant pleural mesothelioma (MPM)...
  9. ncbi Pathological and molecular biological approaches to early mesothelioma
    Tohru Tsujimura
    Department of Pathology, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Int J Clin Oncol 17:40-7. 2012
    ..In this review, we discuss major issues on pathological and molecular biological approaches for diagnosis of early-stage MPM of epithelial type...
  10. ncbi Well-differentiated papillary mesothelioma with invasion to the chest wall
    Ikuko Torii
    Department of Pathology, Hyogo College of Medicine, 1 1 Mukogawa, Nishinomiya, Hyogo 663 8501, Japan
    Lung Cancer 67:244-7. 2010
    ..In addition, tumor cells invaded into the chest wall with a trabecular or glandular architecture. Based on these findings, this case is pathologically considered as WDPM of the pleura with malignant potential...
  11. ncbi Alveolar adenoma of the lung: a case report
    Nobuyuki Kondo
    Department of Thoracic Surgery, Hyogo College of Medicine, 1 1 Mukogawacho, Nishinomiya, Hyogo, Japan
    Ann Thorac Cardiovasc Surg 17:71-3. 2011
    ..These findings indicated that the tumor is alveolar adenoma of the lung. The course of disease remains uneventful, one year after the resection...
  12. ncbi Establishment of a cell line from a Japanese patient useful for generating an in vivo model of malignant pleural mesothelioma
    Ayuko Sato
    Department of Pathology, Hyogo College of Medicine, Hyogo, Japan
    Cancer Sci 102:648-55. 2011
    ..The in vivo model using MM56 cells may be useful for studying the biological behavior of malignant pleural mesothelioma and developing its diagnostic and therapeutic strategies...
  13. ncbi Circulating tumor cells in pulmonary venous blood of primary lung cancer patients
    Yoshitomo Okumura
    Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan
    Ann Thorac Surg 87:1669-75. 2009
    ..4% of resectable lung cancer patients, we conducted a prospective study on CTC in pulmonary vein (PV) blood because tumor cells apart from the primary tumor may circulate after passing through the drainage PV...
  14. ncbi [Exploratory study on the detection of markers for diagnosing early-stage malignant mesothelioma]
    Kazuya Fukuoka
    Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
    Nihon Eiseigaku Zasshi 66:553-7. 2011
    ....
  15. ncbi Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells
    Yoshie Yoshikawa
    Department of Genetics, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Int J Oncol 39:1365-74. 2011
    ....
  16. ncbi Perivascular epithelioid cell tumor of the rib
    Ikuko Torii
    Department of Pathology, Hyogo College of Medicine, 1 1 Mukogawa, Nishinomiya, Hyogo 663 8501, Japan
    Virchows Arch 452:697-702. 2008
    ..To the best of our knowledge, this is the first case report of PEComa arising from the rib with the signs of malignant potential...
  17. ncbi Recurrence of bilateral diffuse bronchiectasis after bilateral lung transplantation
    Fengshi Chen
    Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan
    Respirology 11:666-8. 2006
    ..LT should be carried out with caution in patients with bilateral diffuse bronchiectasis. When performing LT in such patients, it is suggested that sinusitis should be controlled perioperatively...
  18. ncbi Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium
    Ayuko Sato
    Department of Pathology, Hyogo College of Medicine, Hyogo, Japan
    Mod Pathol 23:1458-66. 2010
    ..We propose that CD146 is a sensitive and specific immunocytochemical marker enabling differential diagnosis of malignant pleural mesothelioma from reactive mesothelium...
  19. ncbi Pulmonary sclerosing hemangioma with metastasis to the mediastinal lymph node
    Hiromichi Katakura
    Department of Thoracic Surgery, Kyoto University, Kyoto, Japan
    Ann Thorac Surg 80:2351-3. 2005
    ..A mediastinal lymph node (no. 7) showed some metastatic tumor cells. As lymph node metastasis from pulmonary sclerosing hemangioma is very rare, we herein report the details of our case...
  20. ncbi [Current status of surgical treatment for malignant pleural mesothelioma]
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan
    Kyobu Geka 64:714-8. 2011
    ..This fact clearly illustrates that patient selection plays a key roll in MPM treatment. An all-Japan clinical study on TMT feasibility is currently underway...
  21. ncbi Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma
    Seiji Matsumoto
    Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, Kyoto, Japan
    Lung Cancer 66:75-9. 2009
    ..We established a MPE model and investigated the therapeutic effects of the administration of serial doses of docetaxel on intrathoracic disseminated foci using an in vivo image system (IVIS)...
  22. ncbi eComment: EPP and P/D: which to choose?
    Seiki Hasegawa
    Hyogo College of Medicine, 1 1 Mukogawacho, Nishinomiya 663 8501, Japan
    Interact Cardiovasc Thorac Surg 7:106. 2008
  23. ncbi [Therapeutic strategies for resectable malignant pleural mesothelioma]
    Seiki Hasegawa
    Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan
    Nihon Geka Gakkai Zasshi 110:338-42. 2009
    ..An all-Japan clinical study of trimodality treatment for MPM is currently underway as a part of a national campaign entitled "Comprehensive Strategy against Asbestos-Related Diseases."..
  24. ncbi Parasternal lymph node metastasis of malignant peritoneal mesothelioma: report of a case
    Shinya Ito
    Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan
    Surg Today 35:782-4. 2005
    ..These findings led to a pathological diagnosis of metastasis to the parasternal lymph node from peritoneal mesothelioma...
  25. ncbi Giant cell tumor of the sternum: a case report and review of the literature
    Hiroyuki Futani
    Department of Orthopaedic Surgery, Hyogo College of Medicine, 1 1 Mukogawa Nishinomiya, Hyogo 663 8501, Japan
    Anticancer Res 28:4117-20. 2008
    ..The initial treatment should be extended curettage followed by filling with PMMA...
  26. ncbi Early onset of ganciclovir-resistant cytomegalovirus infection in a lung-transplant recipient
    Fengshi Chen
    Department of Thoracic Surgery, Kyoto University, Japan
    Jpn J Thorac Cardiovasc Surg 53:562-4. 2005
    ..However, she suffered ganciclovir-resistant CMV infection during prophylactic therapy. She was successfully treated with foscarnet, and is now alive without recurrence 18 months after surgery...
  27. ncbi Sustained improvement in cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib
    Hiroya Tamaki
    Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo 663 8501, Japan
    Int J Hematol 92:655-8. 2010
    ....
  28. ncbi Pulmonary dissemination of tumor cells after extended resection of thyroid carcinoma with cardiopulmonary bypass
    Seiki Hasegawa
    Department of Thoracic Surgery, Kyoto University, Kyoto, Japan
    J Thorac Cardiovasc Surg 124:635-6. 2002
  29. ncbi Tracheobronchoplasty for resection of lung cancer arising from a tracheal bronchus
    Masaaki Sato
    Department of Thoracic Surgery, Kyoto University Hospital, Japan
    Ann Thorac Surg 73:310-2. 2002
    ..Tracheobronchoplasty was needed for complete resection of the tumor. Because of the anatomical characteristics of the tracheal bronchus, special surgical techniques for resection of the neoplasm were needed...
  30. ncbi Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer
    Shinya Ishikawa
    Department of Thoracic Surgery, Kyoto University, Faculty of Medicine, Kyoto, Japan
    Clin Cancer Res 10:6579-85. 2004
    ....
  31. ncbi A case of congenital pulmonary vein stenosis in an adult
    Mitsugu Omasa
    Department of Thoracic Surgery, Kyoto University, Kyoto, Japan
    Respiration 71:92-4. 2004
    ..Since the autopsy findings revealed that all 4 pulmonary veins were extremely stenotic due to hypoplasia, she was diagnosed as having had congenital pulmonary vein hypoplasia with stenosis...
  32. ncbi Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer
    Kazumasa Takenaka
    Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, Shogoin-kawahara-cho 54, Sakyo-ku, Kyoto, 606-8507, Japan
    Ann Surg Oncol 12:817-24. 2005
    ..031). RECK expression in involved N2 nodes was significantly higher than in primary tumors (P < .001). CONCLUSIONS: RECK status was a novel prognostic factor in pathologic stage IIIA N2 NSCLC...
  33. ncbi Mediastinal epithelioid hemangioendothelioma resected by hemi-plastron window technique
    Noritaka Isowa
    Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Japan
    Ann Thorac Surg 74:567-9. 2002
    ..The patient had an uneventful postoperative course and no recurrence of tumor 28 months after surgical treatment. We describe this surgical approach and discuss its advantage for cervicothoracic tumors...
  34. ncbi Surgery for pulmonary nodules in breast cancer patients
    Fumihiro Tanaka
    Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, Kyoto, Japan
    Ann Thorac Surg 79:1711-4; discussion 1714-5. 2005
    ..The nature of pulmonary nodules that appeared in patients who had received surgery for breast cancer, as well as the role of surgery for such pulmonary nodules, remains unclear...
  35. ncbi [Advanced lung cancer of performance status 3 successfully treated by gefitinib--a case report]
    Takatoyo Kambayashi
    Dept. of Surgery, Kyoto Min-iren, The Second Center Hospital
    Gan To Kagaku Ryoho 31:223-6. 2004
    ..Not only was the tumor controlled but rapid relief of severe cancer-induced pain was achieved...
  36. ncbi [A case of endobronchial squamous cell lung cancer successfully treated with weekly chemotherapy of carboplatin and paclitaxel]
    Takatoyo Kambayashi
    Dept. of Thoracic Surgery, School of Medicine, Kyoto University
    Gan To Kagaku Ryoho 30:841-4. 2003
    ..Pathological examination revealed no metastases in the lymph nodes. The patient has continued to receive chemotherapy as an outpatient and has been well without recurrence of any metastases for over 16 months...
  37. ncbi Preoperative risk factors for prolonged air leak following lobectomy or segmentectomy for primary lung cancer
    Noritaka Isowa
    Eur J Cardiothorac Surg 21:951. 2002